We are live on !
Find out more
CRCM LP Portfolio holdings
AUM
$152M
Turnover
53.33%
1-Year Est. Return
26.3%
This Fund
S&P 500
This Quarter Est. Return
-15.64%
1 Year Est. Return
+26.3%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$152M
AUM Growth
+$10.9M
(+7.7%)
Cap. Flow
+$44.5M
Cap. Flow % of AUM
Cap. Flow %
29.28%
Top 10 Holdings %
Top 10 Hldgs %
98.7%
Holding
15
New
7
Increased
4
Reduced
2
Closed
1
Avg Time Held
0.6
years
Top 10 Avg Time Held
0.7
years
Top 20 Avg Time Held
0.6
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Bitcoin Trust
IBIT
|
+$12.3M |
| 2 |
BitGo Holdings
BTGO
|
+$10.8M |
| 3 |
Atrium Therapeutics
RNA
|
+$8.38M |
| 4 |
iShares Gold Trust
IAU
|
+$5.43M |
| 5 |
iShares 0-3 Month Treasury Bond ETF
SGOV
|
+$4.75M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
STAAR Surgical
STAA
|
+$1.87M |
| 2 |
Burning Rock Biotech
BNR
|
+$993K |
| 3 |
PCSC
Perceptive Capital Solutions
PCSC
|
+$211K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 74.99% |
| 2 | Healthcare | 7.3% |
| 3 | Financials | 6.25% |
| 4 | Technology | 5% |
| 5 | Consumer Discretionary | 4.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
1
iShares Gold Trust
IAU
$59.2B
| $99.2M | 65.2% |
1,313,821
+63,951
| +5% | +$5.43M |
2024 Q1
9 quarters
|
|
|
2
iShares Bitcoin Trust
IBIT
$65.4B
| $10.1M | 6.64% |
+303,555
| New | +$12.3M |
2026 Q2
0 quarters
|
|
|
3
Atrium Therapeutics
RNA
$138M
| $8.63M | 5.67% |
+641,539
| New | +$8.38M |
2026 Q2
0 quarters
|
|
4
AI Financial Corp
AIFC
$40.5M
| $7.43M | 4.88% |
12,701,530
+90,000
| +0.7% | +$75.4K |
2025 Q3
3 quarters
|
|
5
Playboy Inc
PLBY
$128M
| $7.02M | 4.62% |
5,757,807
+1,412,290
| +32% | +$2.14M |
2024 Q4
6 quarters
|
|
|
6
BitGo Holdings
BTGO
$654M
| $6.8M | 4.47% |
+1,312,171
| New | +$10.8M |
2026 Q2
0 quarters
|
|
|
7
iShares 0-3 Month Treasury Bond ETF
SGOV
$116B
| $4.76M | 3.13% |
+47,241
| New | +$4.75M |
2026 Q2
0 quarters
|
|
8
Vizsla Silver
VZLA
$1.12B
| $2.8M | 1.84% |
+848,216
| New | +$2.95M |
2026 Q2
0 quarters
|
|
|
9
Burning Rock Biotech
BNR
$130M
| $1.77M | 1.17% |
211,997
-70,100
| -25% | -$993K |
2024 Q4
6 quarters
|
|
10
ProCap Acquisition Corp
PCAP
$330M
| $1.65M | 1.09% |
160,656
+8,289
| +5% | +$84.9K |
2025 Q3
3 quarters
|
|
|
PCSC
11
DELISTED
Perceptive Capital Solutions
PCSC
| $1.06M | 0.7% |
97,265
-18,980
| -16% | -$211K |
2025 Q4
2 quarters
|
|
12
First Tracks Biotherapeutics
TRAX
$1.56B
| $711K | 0.47% |
+35,340
| New | +$661K |
2026 Q2
0 quarters
|
|
13
USBC Inc
USBC
$173M
| $174K | 0.11% |
555,325
| – | – |
2025 Q3
3 quarters
|
|
|
14
ProCap Acquisition Corp Warrant
PCAPW
$2.36M
| $32.9K | 0.02% |
+102,735
| New | +$32.6K |
2026 Q2
0 quarters
|
|
|
15
STAAR Surgical
STAA
$1.13B
| – | – |
-100,000
| Closed | -$1.87M | – |
|
Similar funds
IA
CRCM LP's Q2 2026 Portfolio in Review
As of Q2 2026, CRCM LP held 15 positions worth $152M, up 7.7% from $141M the previous quarter. Its ten largest holdings account for 99% of the portfolio.
CRCM LP deployed $44.5M of net new capital in Q2 2026, opening 7 new positions and adding to 4 existing holdings. Its largest new stake was iShares Bitcoin Trust: 303,555 shares worth $10.1M.
By sector, the portfolio is most concentrated in Miscellaneous at 75% of assets, down from 79% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Burning Rock Biotech, an estimated $993K trimmed.
- CRCM LP's largest Q2 2026 buy was iShares Bitcoin Trust: 303,555 shares worth $10.1M.
- CRCM LP added most to iShares Gold Trust in Q2 2026, an estimated $5.43M increase.
- CRCM LP's biggest Q2 2026 reduction was Burning Rock Biotech, cutting an estimated $993K.
- CRCM LP fully exited STAAR Surgical in Q2 2026, selling an estimated $1.87M.
- CRCM LP's ten largest holdings make up 99% of its $152M portfolio in Q2 2026.
- CRCM LP opened 7 new positions and closed 1 in Q2 2026.
- CRCM LP's portfolio value rose 7.7% quarter-over-quarter to $152M.
Based on CRCM LP's 13F filing for Q2 2026, filed 12 Aug 2026.